Cargando…
An 81-Year-Old Man with a 6-Year History of Chronic Lymphocytic Leukemia Presenting with Disease Flare Following Ibrutinib Discontinuation
Patient: Male, 81-year-old Final Diagnosis: Chronic lymphocytic leukemia Symptoms: Fever Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm and the most common leukemia in adults in W...
Autores principales: | Pozzi, Stefano, Potenza, Leonardo, Giusti, Davide, Colaci, Elisabetta, Pioli, Valeria, Leonardi, Giovanna, Maccaferri, Monica, Luppi, Mario, Marasca, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427125/ https://www.ncbi.nlm.nih.gov/pubmed/36016481 http://dx.doi.org/10.12659/AJCR.935941 |
Ejemplares similares
-
Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
por: Fiorcari, Stefania, et al.
Publicado: (2021) -
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib
por: Maffei, Rossana, et al.
Publicado: (2015) -
Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2022) -
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2016) -
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches
por: Lagreca, Ivana, et al.
Publicado: (2022)